申请人:Nir Uri
公开号:US20110086861A1
公开(公告)日:2011-04-14
Provided is a pharmaceutical composition including as an active component a compound of formula (I):
wherein X and (R
1
)
n
are as defined, and a physiological acceptable carrier. Also provided is a method for treating cancer including administering to an individual in need of such treatment an effective amount of the presently described pharmaceutical composition.